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To clone the first anion channel from Xenopus laevis (X. laevis), we isolated a calcium-activated chloride
channel (CLCA)-like membrane protein 6 gene (CMP6) in X. laevis. As a first step in gene isolation, an
expressed sequence tags database was screened to find the partial cDNA fragment. A putative partial
cDNA sequence was obtained by comparison with rat CLCAs identified in our laboratory. First stranded
cDNA was synthesized by reverse transcription polymerase-chain reaction (RT-PCR) using a specific
primer designed for the target cDNA. Repeating the 5' and 3' rapid amplification of cDNA ends, full-
length cDNA was constructed from the cDNA pool. The full-length CMP6 cDNA completed via 5'- and 3'-
RACE was 2,940 bp long and had an open reading frame (ORF) of 940 amino acids. The predicted 940
polypeptides have four major transmembrane domains and showed about 50% identity with that of rat
brain CLCAs in our previously published data. Semi-quantification analysis revealed that CMP6 was most
abundantly expressed in small intestine, colon and liver. However, all tissues except small intestine, colon
and liver had undetectable levels. This result became more credible after we did real-time PCR
quantification for the target gene. In view of all CLCA studies focused on human or murine channels, this
finding suggests a hypothetical protein as an ion channel, an X. laevis CLCA.
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The genomic information of primary laboratory animals
such as mouse and rat was revealed in the genome project
[1,2]. On the basis of those gene constructions in the genome,
various gene families were identified for the study of gene
function contributing to the scientific needs.
The calcium-activated chloride channel (CaCC) family has
been summarized as a group of anion channels that are
activated by release of calcium from the endoplasmic reticulum
(ER) [3,4]. The CaCC family has at least two types of chloride
channels: TMEM16 channels [5-7] and chloride channels
calcium-activated (CLCA). Even though this family show a
common characteristic of being activated by release of calcium
from the ER, there is little genetic and molecular similarity
between the two CaCC families [3,4].
Recently, two different CaCCs, xTMEM16A and xANO2,
were cloned as Xenopus laevis (X. laevis) CaCCs [8,9]. These
two TMEM16 channels, also called anoctamin, have very
significant molecular and physiological characteristics. In our
research of anoctamin, tissue distribution analysis revealed
a ubiquitous expression pattern in various X. laevis tissues
including intestines [9].
With a focus on function, calcium-activated chloride
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channels (CLCAs) have been studied in a number of species
including bovine [10], murine [11,12], human [13], and
porcine [14]. We reported two CLCAs isolated from one
laboratory animal, Ratus norvegicus [15,16]. These rbCLCA1
and rbCLCA2 channels have common characteristics such
as primary molecular structure and expression profiles.
As mentioned above, CLCAs from various animal species
and tissues have been studied except X. laevis. Moreover,
most of the studies were more likely to focus on diseases
or functions of humans, and the molecular characterization
of the channels tended to be neglected. Here we report
a putative CLCA-like membrane protein 6 gene (CMP6) in
X. laevis on the basis of its primary molecular structure and
tissue distribution profiles.
Materials and Methods
Materials
Chemical reagents were purchased from BioPure (Burlington,
Ontario, Canada). pGEM
®-T Easy vector was from Promega
(Madison, WI, USA). A peltier thermal cycler PTC-200 cycler
was purchased from BIO-RAD (Hercules, CA, USA). Female
X. laevis (Xenopus I, Ann Arbor, MI, USA) frog was kindly
provided by Dr. S.Y. Nah (Konkuk University, Seoul, Korea).
Database search on X. laevis expressed sequence
tags (EST) and analysis
An EST database search was conducted on X. laevis to
find out whether there are any partial cDNAs that show high
homology with mouse CLCA sequences. First, BLAST server
on NCBI was utilized as a search tool to find the X. laevis
EST partial cDNA sequence. Highly homologous partial cDNAs
were found from EST clones, and among them, a partial
cDNA showing 50% nucleotide homology was selected. The
amino acid sequence indicated that the sequence was aligned
and we compared it to mouse CLCAs (Figure 1A). The amino
acid sequence exceeding 45% homology was extracted from
a protein database and the intermediate results confirmed
that the sequences were significant enough to proceed to
the next step. Sequences showing too high or too low homology
were not considered candidate sequences and were excluded.
Finally, a partial cDNA was selected as a candidate for cloning. 
The screening of Xenopus EST database in the NCBI was
conducted to query the target sequence. To search for partial
cDNAs as candidates for cloning, a partial cDNA (DC066238)
was screened. DC066238 cDNA was utilized to generate
gene specific primers including C218 for completion of the
whole cDNA sequence (Table 1).
RNA preparation
Total RNAs were extracted from X. laevis tissues with easy-
BLUE (iNtRON Biotechnology, Seongnam, Korea) according
to the user's manual with some modifications. To avoid
genomic DNA contamination, the extracted total RNA samples
were digested with RNase free DNase I (Invitrogen, San Diego,
CA, USA) prior to use.
First strand cDNA synthesis and rapid amplification
of cDNA ends (RACE)
Reverse transcription reactions were performed with 10
µg of total RNA using gene specific primers (10 pmol/µL)
and dNTPs. To anneal the RNA and the primers, RNA was
heat denatured at 65
oC for 5 min as a conditioning of the
RNA-primer mixture. The reaction mixture was as follows:
nuclease-free water, 100 mM DTT, RNase inhibitor, and
Superscript III RTase, The mixture was incubated at 50
oC
for 30 min and at 55
oC for 30 min, and RNA was destroyed
by a final concentration of 0.5 M sodium hydroxide. After
ethanol precipitation with one-tenth volume of sodium
acetate, the reaction product was resuspended in 20 µL of
nuclease-free water for 3'-RACE. 5' kination of the cDNA
and linker-attachment for the 5'-RACE were performed for
effective construction. After all the steps, Purification was done
using Sephacryl
® S-400 to remove the excessive oligoprimers.
The 5'- and 3'-RACE methods were employed with gene
specific primers and an oligo-d(T). These two rounds of RACE
reactions were repeated for the amplification of full-length
cDNA as shown in Figure 1B. Table 1 represents primer sets
used on completion of the two rounds of RACE and
construction of a subcloning plasmid. To avoid any match
errors of the PCR and RACE reaction, KOD-Plus Taq
polymerase (Toyobo, Osaka, Japan) was used through
amplification of cDNA. Reaction conditions were as follows:
94
oC for 2 min, 30 cycles of 94
oC for 30 sec, 60
oC for 30
sec, and 68
oC for 1-3 min for the first PCR; for the second
PCR, 94
oC for 2 min, 30 cycles of 94
oC for 30 sec, 60
oC
for 30 sec, and 68
oC for 1-3 min.
Full-length cDNA construction
After the two rounds of RACE, Round 1 and Round 2
sub-clones were connected by a recombinant PCR method.
Two amplified cDNAs of the 5' and 3' terminuses were used
as the overlapping templates together with each piece of
DNA to complete a full-length cDNA. C407, C409, and C408
primers were designed from the 5'- and 3'-UTRs. These primer
sets for the final step of the recombinant PCR were used
for the amplification of full-length cDNA. All these primersFirst CLCA-like gene in Xenopus laevis 111
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are summarized in Table 1. To clone the full-length cDNA,
a recombinant PCR product was inserted into a pGEM
®-T
Easy subcloning vector (Promega). The CMP6 cDNA was
confirmed by sequence analysis. For sequence analysis, each
cDNA obtained from RACE was tailed with poly-A, ligated
with the above vector, and transformed with E. coli DH5α
strain. Sequence determination was performed using an ABI
PRISM system, and homology alignment and analysis were
conducted on an NCBI-BLAST server.
Tissue distribution analysis by RT-PCR
To perform RT-PCR, first cDNA was synthesized from RNA
as described in Materials and Methods. Two rounds of PCR
were carried out for the 45 repeats to determine the specific
products of CMP6. These procedures were carried out in
a Peltier thermal cycler PTC-200. For semi-quantification of
PCR, nine tissue RNAs (brain, heart, lung, liver, small intestine,
colon, kidney, spleen, and oocytes) were employed. In this
RT-PCR, i-StarTaq™ polymerase (iNtRON Biotechnology) was
Figure 1. CMP6 cDNA isolation. (A) Sequence alignment of DC066238. Amino acid (aa) alignment was deduced by querying the
DC066238 amino acid sequence using GENETYX. The amino acid homology is indicated as follows: identical (asterisk), very
similar (double dot) and similar (dot). (B) The strategy is shown for generating full-length cDNA. First strand cDNA (dotted) and
PCR products (thick) are shown with black lines. CMP6: 5'-RACE and 3'-RACE products represent Round 1 and Round 2,
respectively. 3'-RACE products are shown in panel (C) lane 1, and 5'-RACE PCR products in (D) lane 1. PCR products were
electrophoresed in a 1% agarose gel. Black arrowheads on panels (C) and (D) indicate the 1,700 and 1,296 bp of target products of
CMP6. Molecular weights are shown for 1 kb Plus size markers (G&P, Anyang, Korea).112 Ra Mi Lee et al.
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used for the stable and fine amplification from nine X. laevis
tissue-derived cDNAs with gene specific primers on a Peltier
thermal cycler PTC 200. The PCR reaction was performed
as follows: pre-denaturation step at 94
oC for 1 min, 20 repeats
of denaturation step at 94
oC for 15 sec, annealing at 55
oC
for 20 sec, extension at 72
oC for 20
oCsec, and for second
PCR, 94 for 1 min, 25 repeats of 94
oC for 15 sec, 57
oC for
20 sec, 72
oC for 1 min. Excess primers were removed by
Sephacryl
® S-400 column chromatography after the first PCR.
Quantitative real-time PCR
To provide a CMP6 quantification result, real-time PCR
was performed to confirm whether any difference between
RT-PCR and real-time PCR existed. In order to maintain
consistency, nine PCR products from reverse-transcription PCR
derived from nine same cDNAs were used in the next
experiment. A CHROMO4™ (BIO-RAD) real-time PCR system
was employed for analysis. DyNAmo™ ColorFlash
® SYBR
Green qPCR kit (Finnzymes Oy, Espoo, Finland) was utilized
with the following steps: pre-denaturation at 95
oC for 7 min,
35 repeats of the denaturation step at 95
oC for 10 sec, at
60
oC for 20 sec, at 72
oC for 20 sec, a final elongation step
at 72
oC for 7 min, and establishment of a melting curve from
65 to 90
oC. Expression levels were calculated using
GeneXpression Macro CHROMO4™ from an Opticon4
program provided by the supplier.
Results
Selection of the target cDNA sequence
The selected partial cDNA, DC066238, has a 630 bp
nucleotide sequence. One ORF codes for a 210 amino acid
sequence. This cDNA was screened by comparison of its
homology to mouse CLCA1 and CLCA6 which showed over
a 48% amino acid similarity (Figure 1A). As a first step in
gene cloning, DC066238 was utilized for primer design to
clone the CMP6 as described in Materials and Methods.
CMP6 gene cloning
To complete the full-length CMP6 cDNA, each cDNA, a
1,700 bp linker-C218 (5'-RACE) and a 1,296 bp C401-adapter
(3'-RACE) were amplified as described in Materials and
Methods (Figure 1B, C, D). It was confirmed that CMP6 had
no base changes or missed sequences over the whole region
(data not shown). As a result, we have successfully isolated
full-length X. laevis CMP6 cDNA including a 2,940 bp sequence
with one ORF of 940 amino acids. We did this using several
repeats of the 3'- and 5'-RACE method and the specific primers
as described in Materials and Methods. The completed CMP6
cDNA contained a short 5'- and a 3'-UTR with a poly (A)
n
tail and a poly-adenylation signal. We registered this cDNA
as a CMP6 gene on the DDBJ database (GenBank Accession
No. AB591378).
Analysis of primary structure
The sequence analysis of the CMP6 gene revealed short
5'- and 3'-UTRs and a single large ORF. The CMP6 protein,
including 940 amino acids, was aligned by CLUSTAL W
software. The rat CLCAs and CMP6 were compared whether
or not it had significant homology or was considered as a
CLCA gene family member. The ORF of X. laevis CMP6 showed
identity exceeding 50% overall to those of rbCLCA1 (Figure
2A and Table 2). According to this alignment, the overall
significant homology that was exhibited led us to regard it
as a new Xenopus CLCA-like member (Table 2).
It has been reported that the general CLCAs have four
or five transmembrane (TM) domains [17]. Although there
are limitations when the actual protein conformation analysis
is absent, computational analysis using an appropriate program
makes it possible to analyze and predict the conformation
of certain protein structures. The hydropathy analysis of CMP6
(Kyte-Doolittle method) indicates that there exist at least four
predicted TM domains as shown in Figure 2B. According
to hydropathy analysis, we were able to propose that CMP6
is a highly homologous CLCA family member.
To determine the unique characteristics of the CLCA family,
the predicted consensus sites were searched for on a GENETYX
program. We found the major characteristics of the CLCA
family such as the sites of N-linked glycosylation, N-
myristoylation, phosphorylation by PKC, casein kinase II and
cAMP-dependent protein kinase (Figure 2A). Also, there was
a predicted signal sequence and a hydrophobic carboxyl
terminus that was regarded as a typical membrane protein
including CLCA.
Table 1. Primer sequence and name
Name Sequence
C218 5' GCTGTTCCTGGGATTTCAAGTC 3'
C401 5' GGGAAAGTGCACTACCTGATC 3'
C407 5' GACCAGGAATATTCCTGCATCG 3'
C408 5' CCAAAGAGAAAACAGTACTATACAGC 3'
C409 5' GAGACGTACCAATTTGTCAAGGAG 3'
XHRMbA1 5' ATGCCATCCTGCGTCTGGACCTG 3'
xbA3 5' CCAATGATGAAGAAGAGGCAG 3'
C415 5' GAGATTGGTGTTTGGTATTACACAT 3'
C417 5' TAAATCCACGGGAGTTCCAG 3'
5'-RACE; C218, 3'-RACE; C401, 5'- and 3'-UTR; C407, C409,
and C408, β-actin; XHRMbA1 and xbA3, and gene-specific;
C415 and C417.First CLCA-like gene in Xenopus laevis 113
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Quantitative analysis of CMP6
In tissue distribution analysis, the amplified PCR products
were detected in some tissues. In particular, we could detect
CMP6 gene products, which were expressed predominantly
in small intestine, colon and liver (Figure 3). The gene-specific
products of CMP6, and β-actin as an internal control, were
shown to be 252 and 159 bp (Figure 3A). The intensity of
each product was calculated using the E-Capt program for
normalization. Relative ratios of CMP6 expression levels in
each tissue were calculated compared to the housekeeping
gene  β-actin (Figure 3B). Each RT-PCR was conducted at
least three times to insure the reliability of the numerical
values. As shown in Figures 3A and 3B, expression levels
were different with small intestine>colon>liver. However,
triple repeats of experiments showed that the probability of
liver expression is very low (no more than one out of four
times; data not shown). In summary, the expression of CMP6
is distinct and specified within the gastrointestinal tract. This
suggests that CMP6 expression patterns are limited to secretory
functions.
Figure 2. Comparison of X. laevis CMP6 primary structure. (A) CMP6 amino acids were aligned by querying with rat CLCAs on
CLUSTAL W. The homology of amino acids of CMP6 is indicated as identical (asterisk) very similar (double dot) and similar (dot).
Consensus sites are marked as follows: N-linked glycosylation (●), N-myristoylation sites (▼), phosphorylation by PKC (#), by
casein kinase II (◇) and by cAMP-dependent protein kinase (+). The predicted signal sequence (SS) and the hydrophobic carboxyl
terminus (H) are overlined. An arrow indicates the predicted cleavage site. (B) Hydropathy analysis. The hydropathy plot was
analyzed by the Kyte-Doolittle method. Hydrophobic domains are given as positive values. The proposed hydrophobic domains are
four segments.114 Ra Mi Lee et al.
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In order to validate data from semi-quantification RT-PCR
analysis, quantitative real-time PCR analysis was conducted
as described in Materials and Methods. The exponential graph
of nine tissues was obtained as the amplification time for
expression intensity (data not shown). Figure 4 shows a bar
graph that was converted from the exponential graph using
numerical values for each product. Expression levels were:
small intestine>colon>liver. It also showed that heart was
amplified a little (data not shown). The real-time PCR data
are completely consistent with the RT-PCR data (Figure 4).
Discussion
Since there were no reports about the CLCA gene family
of X. laevis, we studied X. laevis CLCA gene family members.
After two rounds of RACE, linker-C218 constructs were first
cloned from X. laevis spleen. However, we could not isolate
the exact match of the C218 sequence in spleen tissue.
Moreover, there were subtle changes in amino acid sequences.
Paradoxically, this kind of difficulty in an experiment suggests
the possibility of the existence of a new CLCA gene. Hence,
we are now screening for more CLCA members in X. laevis.
In this study, a 2,940 bp cDNA of CMP6 was successfully
cloned from X. laevis (Figure 1). As mentioned above, it has
been reported that two bovine CLCAs, and five or more
murine and human homologs were isolated, but not from
X. laevis. Also, two rat brain CLCAs showed lengths around
2,800 bp [15,16]. As regards animal CLCAs, it is meaningful
to identify CLCA genes in unstudied animal species. Under
homology-based conditions, we can propose that CMP6 may
be a functional CLCA. This cDNA was similar to the rat CLCA
sequences showing 56% homology for the nucleotide
sequence, and a 50% homology for the amino acid sequence
[15,16]. There was a low 21% similarity in the restricted partial
Table 2. Overall percentages of amino acid homology for CMP6
Gene Homology (%)
mCLCA1 50.64
mCLCA2 50.35
mCLCA3 45.52
mCLCA4 49.04
mCLCA5 42.39
mCLCA6 48.13
hCLCA1 47.79
hCLCA2 47.07
hCLCA2 45.29
hCLCA2 47.07
rbCLCA1 50.06
rbCLCA2 49.94
Mouse, human and rat brain are indicated by m, h and rb
prefixes, respectively.
Figure 3. Tissue distribution of CMP6 expression in X. laevis.
(A) RT-PCR products in various tissues. The amplified PCR
products were electrophoresed in a 2% agarose gel. The
specific RT-PCR products are a 252 bp CMP6 (C415 and
C416) and a 159 bp β -actin gene as an internal control
(XHRMbA1 and xbA3). Expression ratios of CMP6 are shown
as relative calculated values for β-actin. (B) CMP6 showed high
expression levels in small intestine intestine (sm int) and colon.
Each graph represents at least three independent experiments.
The bars shown in the graph are mean±SD. *P<0.05 compared
to control group. 
Figure 4. CMP6 quantification by real-time PCR. Relative
quantification is shown as a bar graph. The relative CMP6
expression ratios for β-actin are shown. This result confirms the
idea of CMP6 being largely expressed in liver, small intestine
(sm int), and colon. The graph represents three independent
experiments with each bar as mean±SD. *P<0.05 compared to
control group.First CLCA-like gene in Xenopus laevis 115
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region of xANO2 [9]. CMP6 shows the most homology (over
50%) to mice CLCA1 and rbCLCA1 (Table 2). Although mouse
CLCA1 (mCLCA1) has the highest homology to CMP6, at
least if similarities are limited to percentages, rbCLCA1 showed
the most homology spanning the overall primary structure
(data not shown).
The primary structure of CMP6 revealed four major potential
TM domains and, in hydropathy analysis using an analysis
window of 17 residues, several minor regions (Figure 2B).
As has been proposed for hCLCA1 or hCLCA2, many CLCA
family members have four or five TM domains [4]. This analysis
is consistent with typical CLCA membrane proteins. On the
contrary, two X. laevis anoctamins, xTMEM16A and xANO2,
have eight distinct TM domains compared to four TM domains
for the CLCA family. These results support the low amino
acid sequence homology between CLCAs and anoctamins.
Loewen et al. divided the CLCA gene family into two groups.
The first group includes hCLCA1, mCLCA3, and pCLCA1.
The second group contains two subgroups – one that contains
mCLCA1, mCLCA2, and mCLCA4, and a second that contains
hCLCA3, bCLCA1, and bCLCA2 [17]. Evans SR et al. reported
two mouse CLCA genes with mCLCA6 expressed primarily
in intestine, stomach and in liver a little, whereas mCLCA5
is widely expressed with particularly strong expression in eye
and spleen [12]. CMP6 was expressed specifically in intestine
(and in liver a little) in contrast to rat CLCAs which were
predominantly expressed in brain [15,16].
Moreover, there were similar molecular characteristics
regarding the far carboxyl terminus (C-terminus) of the primary
structures between CMP6, and mCLCA6 and mCLCA4. This
was in contrast to other CLCAs that had no similarity with
the C-terminus of CMP6. The C-terminus of CMP6 was most
similar to that of mCLCA6 whereas mCLCA4 was less similar
(data not shown). Even though we have no evidence for
a relation between function and similarities at the C-terminus,
we can assume that CMP6 is key in the gastrointestinal tract,
especially mucus production. This type of CLCA-like protein
might be involved in the regulation of chloride conductance
in epithelium with secretory functions. For a more defined
study in the future, further work will be needed using
heterologous expression analyses.
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